Amplyx Pharmaceuticals

About:

Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems

Website: http://www.amplyx.com/

Twitter/X: amplyxpharma

Top Investors: Pfizer, Sofinnova Investments, New Enterprise Associates, Tech Coast Angels, Adage Capital Management

Description:

Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.